[go: up one dir, main page]

IL147214A0 - 1-methylcarbapenem derivatives and pharmaceutical compositions containing the same - Google Patents

1-methylcarbapenem derivatives and pharmaceutical compositions containing the same

Info

Publication number
IL147214A0
IL147214A0 IL14721400A IL14721400A IL147214A0 IL 147214 A0 IL147214 A0 IL 147214A0 IL 14721400 A IL14721400 A IL 14721400A IL 14721400 A IL14721400 A IL 14721400A IL 147214 A0 IL147214 A0 IL 147214A0
Authority
IL
Israel
Prior art keywords
same
pharmaceutical compositions
compositions containing
methylcarbapenem derivatives
methylcarbapenem
Prior art date
Application number
IL14721400A
Other languages
English (en)
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of IL147214A0 publication Critical patent/IL147214A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL14721400A 1999-07-06 2000-07-06 1-methylcarbapenem derivatives and pharmaceutical compositions containing the same IL147214A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP19136899 1999-07-06
PCT/JP2000/004496 WO2001002401A1 (en) 1999-07-06 2000-07-06 Crystalline 1-methylcarbapenem compounds

Publications (1)

Publication Number Publication Date
IL147214A0 true IL147214A0 (en) 2002-08-14

Family

ID=16273433

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14721400A IL147214A0 (en) 1999-07-06 2000-07-06 1-methylcarbapenem derivatives and pharmaceutical compositions containing the same
IL147214A IL147214A (en) 1999-07-06 2001-12-20 1-methylcarbapenem derivatives and pharmaceutical compositions containing the same

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL147214A IL147214A (en) 1999-07-06 2001-12-20 1-methylcarbapenem derivatives and pharmaceutical compositions containing the same

Country Status (21)

Country Link
US (3) US20020128254A1 (es)
EP (1) EP1193269A4 (es)
JP (1) JP3476420B2 (es)
KR (1) KR100750552B1 (es)
CN (2) CN100360530C (es)
AU (1) AU758190B2 (es)
BR (1) BR0012253A (es)
CA (1) CA2378483C (es)
CZ (1) CZ20014731A3 (es)
HK (1) HK1044768A1 (es)
HU (1) HUP0202255A3 (es)
IL (2) IL147214A0 (es)
MX (1) MXPA02000061A (es)
NO (1) NO327786B1 (es)
NZ (1) NZ516310A (es)
PL (1) PL352296A1 (es)
RU (2) RU2214411C2 (es)
TR (2) TR200403436T2 (es)
TW (1) TWI250160B (es)
WO (1) WO2001002401A1 (es)
ZA (1) ZA200110413B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020060067A (ko) 1999-04-06 2002-07-16 가와무라 요시부미 α-치환 카르복실산 유도체
US7041660B2 (en) * 1999-07-06 2006-05-09 Sankyo Company, Limited Crystalline 1-methylcarbapenem derivatives
ATE267831T1 (de) * 1999-09-30 2004-06-15 Otsuka Kagaku Kk Kristalle von cephemderivaten und verfahren zu ihrer herstellung
PT1294361E (pt) 2000-06-21 2011-07-26 Cubist Pharm Inc Composições e métodos para melhorar a absorção oral de agentes antimicrobianos
KR100451672B1 (ko) * 2001-06-05 2004-10-08 한미약품 주식회사 결정성 세프디니르 산부가염, 이의 제조방법 및 이를이용한 세프디니르의 제조방법
EP1426376A4 (en) * 2001-08-13 2004-12-22 Eisai Co Ltd PROCESS FOR THE PREPARATION OF CARBAPENEM-BASED ANTIBIOTICS
HRP20040264B1 (en) * 2001-09-26 2012-07-31 Merck@Sharp@@@Dohme@Corp Process for making carbapenem compounds
ATE518864T1 (de) * 2001-09-26 2011-08-15 Merck Sharp & Dohme Verfahren zur herstellung von carbapenemverbindungen
ITMI20012364A1 (it) * 2001-11-09 2003-05-09 Antibioticos Spa Processo di sintesi della cefixima via alchil-o arilsolfonati
CN100475817C (zh) * 2003-08-25 2009-04-08 三共株式会社 1-甲基碳青霉烯化合物的结晶
JP2005097278A (ja) * 2003-08-25 2005-04-14 Sankyo Co Ltd 1−メチルカルバペネム化合物の結晶
EP1776365B1 (en) * 2004-06-02 2011-08-03 Sandoz Ag Meropenem intermediate in crystalline form
EP1862456A4 (en) * 2005-03-22 2010-01-27 Daiichi Sankyo Co Ltd PROCESS FOR PREPARING A CARBAPENE DERIVATIVE WITH 1-ALKYLPYRROLIDINE STRUCTURE
US8968781B2 (en) 2005-04-29 2015-03-03 Cubist Pharmaceuticals, Inc. Therapeutic compositions
JPWO2006121151A1 (ja) * 2005-05-13 2008-12-18 第一三共株式会社 1−メチルカルバペネム化合物の結晶
CN101328179B (zh) * 2007-06-15 2011-01-12 山东轩竹医药科技有限公司 含有氧代氮杂环的巯基吡咯烷培南衍生物
CN101412717B (zh) * 2007-10-19 2011-01-12 山东轩竹医药科技有限公司 含有胍基烷酰胺基杂环的碳青霉烯衍生物
WO2009091031A1 (ja) * 2008-01-17 2009-07-23 Dainippon Sumitomo Pharma Co., Ltd. アデニン化合物の製造方法
WO2011143935A1 (zh) * 2010-05-21 2011-11-24 山东轩竹医药科技有限公司 碳青霉烯衍生物或其水合物的晶型及其制备方法与用途
US8822445B2 (en) * 2010-06-03 2014-09-02 Xuanzhu Pharma Co., Ltd. Crystalline form of carbapenem derivative or its hydrates and preparation methods and uses thereof
EP2945929B1 (de) * 2013-01-15 2020-01-22 Merck Patent GmbH Acylguanidine zur behandlung von arthrose

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4260543A (en) 1978-07-03 1981-04-07 Merck & Co., Inc. Crystalline N-formimidoyl thienamycin
US4748238A (en) 1984-03-14 1988-05-31 Merck & Co., Inc. Crystalline 1R,5S,6S,8R-1-methyl-2-(N,N-dimethylcarbamimidoylmethylthio)-6-(1-hydroxyethyl)-1-carbapen-2-em-3-carboxylic acid
US4713451A (en) 1984-04-09 1987-12-15 Merck & Co., Inc. Crystalline dimethyliminothienamycin
IE60588B1 (en) 1986-07-30 1994-07-27 Sumitomo Pharma Carbapenem compound in crystalline form, and its production and use
US4866171A (en) 1987-04-11 1989-09-12 Lederle (Japan), Ltd. (1R,5S,6S)-2-[(6,7-dihydro-5H-pyrazolo[1,2-a][1,2,4]triazolium-6-yl)]thio-6-[R-1-hydroxyethyl]-1-methyl-carbapenum-3-carboxylate
CA2036163C (en) * 1990-02-14 2001-06-19 Makoto Sunagawa Novel beta-lactam compounds and their production
TW209220B (es) * 1991-11-27 1993-07-11 Manyu Seiyaku Kk
GB9202298D0 (en) * 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
DE69324106T2 (de) 1992-11-17 1999-12-09 Sankyo Co., Ltd. Krystallines Carbapenemderivat
JPH06336483A (ja) * 1993-05-26 1994-12-06 Banyu Pharmaceut Co Ltd アミノアルキルピロリジニルチオカルバペネム誘導体
JPH07291973A (ja) * 1994-04-27 1995-11-07 Banyu Pharmaceut Co Ltd 新規な2−ピロリジニルチオカルバペネム誘導体
JPH09110869A (ja) * 1995-10-23 1997-04-28 Lederle Japan Ltd カルバペネム化合物
DK0882728T3 (da) * 1995-12-21 2003-01-06 Sankyo Co 1-methylcarbapenemderivater
JP2955276B2 (ja) * 1997-06-19 1999-10-04 三共株式会社 1−メチルカルバペネム誘導体を含有する抗菌剤

Also Published As

Publication number Publication date
KR100750552B1 (ko) 2007-08-20
MXPA02000061A (es) 2002-07-02
WO2001002401A1 (en) 2001-01-11
CA2378483C (en) 2008-09-16
US6924279B2 (en) 2005-08-02
TWI250160B (en) 2006-03-01
HK1044768A1 (en) 2002-11-01
CN100360530C (zh) 2008-01-09
AU5848700A (en) 2001-01-22
JP3476420B2 (ja) 2003-12-10
JP2001072681A (ja) 2001-03-21
HUP0202255A2 (en) 2002-10-28
AU758190B2 (en) 2003-03-20
TR200403436T2 (tr) 2005-03-21
IL147214A (en) 2009-12-24
PL352296A1 (en) 2003-08-11
CA2378483A1 (en) 2001-01-11
CN1372560A (zh) 2002-10-02
CZ20014731A3 (cs) 2002-04-17
RU2003118411A (ru) 2004-12-20
US20020128254A1 (en) 2002-09-12
US20030232803A1 (en) 2003-12-18
CN101077869A (zh) 2007-11-28
NO327786B1 (no) 2009-09-21
KR20020022761A (ko) 2002-03-27
EP1193269A1 (en) 2002-04-03
ZA200110413B (en) 2003-03-19
HUP0202255A3 (en) 2003-10-28
US20030158174A1 (en) 2003-08-21
TR200200100T2 (tr) 2002-05-21
BR0012253A (pt) 2002-03-26
RU2214411C2 (ru) 2003-10-20
NO20020030L (no) 2002-03-05
NZ516310A (en) 2004-05-28
NO20020030D0 (no) 2002-01-04
EP1193269A4 (en) 2003-05-28

Similar Documents

Publication Publication Date Title
IL138899A0 (en) Amidene derivatives and pharmaceutical compositions containing the same
IL152451A0 (en) 2-chloro-2-nitrophenylcarboxamide derivatives and pharmaceutical compositions containing the same
HUP0301178A3 (en) Glucopyranosyloxybenzylbenzene derivatives and pharmaceutical compositions containing the same
IL144977A0 (en) Pyrrolotriazine derivatives and pharmaceutical compositions containing the same
IL153123A0 (en) N-ureidoheterocycloalkyl-piperidine derivatives and pharmaceutical compositions containing the same
IL140862A (en) Thiobenzimidazole derivatives and pharmaceutical compositions containing the same
IL149757A0 (en) Aminothiazole derivatives and pharmaceutical compositions containing the same
IL202633A0 (en) Sulfonamide derivatives and pharmaceutical compositions containing the same
EG24066A (en) Novel quinuclidine derivatives and medicinal compositions containing the same
IL148517A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
IL150077A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
HUP0103406A3 (en) 1h-imidazopyridine derivatives and pharmaceutical compositions thereof
IL143920A0 (en) 3-heteroarylidenyl-2-indolinone derivatives and pharmaceutical compositions containing the same
IL141456A0 (en) Rhodanine derivatives and pharmaceutical compositions containing the same
IL150224A0 (en) Lipopeptides and pharmaceutical compositions containing the same
IL150223A0 (en) Lipopeptides and pharmaceutical compositions containing the same
IL150734A0 (en) Azaindole derivatives and pharmaceutical compositions containing the same
IL161616A0 (en) Indazolypyrrolotriazine derivatives and pharmaceutical compositions containing the same
IL149883A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
HUP0102990A3 (en) Tetrahydroimidazo-naphtyridine derivatives and pharmaceutical compositions thereof
IL158044A0 (en) Cyclopropylindole derivatives and pharmaceutical compositions containing the same
IL158300A0 (en) Bisarylimidazol derivatives and pharmaceutical compositions containing the same
IL156812A0 (en) Phthalazinone-piperidino derivatives and pharmaceutical compositions containing the same
IL133097A0 (en) Aroyl-piperazine derivatives pharmaceutical compositions containing the same and the use thereof
IL143802A0 (en) Imidazole derivatives and pharmaceutical compositions containing the same